Showing results (521-530 of 606) with videos related to

Sort By:
Pageof 61
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|September 19, 1997
Phase II trial of 96-hour paclitaxel plus oral estramustine phosphate in metastatic hormone-refractory prostate cancerG R Hudes, F Nathan, C Khater, et al.
Journal of Virology|December 19, 2000
Kinetics of hepadnavirus loss from the liver during inhibition of viral DNA synthesisY Zhu, T Yamamoto, J Cullen, et al.
BJU International|August 18, 2005
A case-control study of risk factors in men with chronic pelvic pain syndromeMichel A Pontari, Mary McNaughton-Collins, Michael P O'leary, et al.
Cancer Research|November 15, 1991
Phase I study of thiotepa in combination with the glutathione transferase inhibitor ethacrynic acidP J O'Dwyer, F LaCreta, S Nash, et al.
Evaluation & the Health Professions|April 27, 2005
Data pooling and analysis to build a preliminary item bank: an example using bowel function in prostate cancerDavid T Eton, Jin-Shei Lai, David Cella, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|November 24, 1999
Phase I trial of multiple cycles of high-dose chemotherapy supported by autologous peripheral-blood stem cellsR J Schilder, S Johnson, J Gallo, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|August 1, 1995
Paclitaxel and carboplatin in combination in the treatment of advanced non-small-cell lung cancer: a phase II toxicity, response, and survival analysisC J Langer, J C Leighton, R L Comis, et al.
Cancer|October 1, 1993
Neoadjuvant chemoradiation in pancreatic and duodenal carcinoma. A Phase II StudyR S Yeung, J L Weese, J P Hoffman, et al.
Annals of Surgery|August 14, 2024
Patient-Reported Preoperative Depression as a Predictor of Psychosocial Outcomes After Gender-Affirming Facial Feminization SurgeryJeremiah M Taylor, Nghiem H Nguyen, Kelly X Huang, et al.
Pageof 61